Osteogenesis Imperfecta - Brittle Bone Intro

- Definition: Inherited connective tissue disorder characterized by fragile bones that fracture easily.
- Aka: Brittle Bone Disease.
- Genetic Basis: Primarily a defect in Type I collagen synthesis.
- Most commonly due to mutations in COL1A1 or COL1A2 genes.
- Inheritance: Predominantly Autosomal Dominant (AD); some rare forms are Autosomal Recessive (AR).
- Pathophysiology: Leads to either:
- Quantitative defect: ↓ production of structurally normal Type I collagen (milder forms).
- Qualitative defect: Production of abnormal Type I collagen (more severe forms).
⭐ OI is the most common inherited bone fragility disorder, affecting approximately 1 in 10,000 to 20,000 births worldwide.
Osteogenesis Imperfecta - Shattered Showcase
- Patho: Type I collagen defect (COL1A1/A2 genes). "Brittle Bone Disease".
- Key Features (📌 "BITE"):
- Bones: Multiple fractures, osteopenia, short stature, bone deformities.
- I (Eyes): Blue sclerae.
- Teeth: Dentinogenesis imperfecta (opalescent, discolored).
- Ear: Hearing loss (conductive/mixed).
- Also: Wormian bones (skull), joint laxity, basilar invagination, easy bruising.
- Sillence Classification (Main Types):
- Type I: Mildest, persistent blue sclerae. AD.
- Type II: Most severe, lethal perinatal. AR/New Mutation.
- Type III: Progressive deforming, variable sclerae. AD/AR.
- Type IV: Intermediate, normal/grey sclerae. AD.
- Dx: Clinical; genetic tests (COL1A1/A2). X-ray: osteopenia, fractures, deformities.
- Rx: Bisphosphonates (IV pamidronate), supportive (PT, OT, surgery).
⭐ Blue sclerae are a hallmark sign, caused by the thinness of the sclera allowing the underlying choroidal pigment to show through.
Osteogenesis Imperfecta - Cracking the Code
- Genetic disorder: Defective type I collagen (COL1A1/COL1A2 genes) → "brittle bone disease".
- Key features: Multiple fractures, blue sclera, hearing loss, dentinogenesis imperfecta (DI), short stature, joint laxity.
Sillence Classification (Simplified)
| Type | Inheritance | Severity | Sclera | Fractures | DI | Other Key Features |
|---|---|---|---|---|---|---|
| I | AD | Mild | Blue | Post-natal, ↓ age | Rare | Most common, hearing loss (50%) |
| II | AD/AR | Perinatal Lethal | Dark Blue | In utero/birth, severe | Variable | Beaded ribs, crumpled femurs |
| III | AD/AR | Prog. Deforming | Blue/Normal | At birth, severe | Common | Very short, triangular facies |
| IV | AD | Moderate | Normal | Variable, bone bowing | Common | Basilar invagination |
- Management: Bisphosphonates (e.g., Pamidronate), fracture care, physiotherapy, surgical correction.
⭐ Wormian bones (sutural bones) are a characteristic X-ray finding in Osteogenesis Imperfecta.
Osteogenesis Imperfecta - Mending the Matrix
- Genetic disorder: Defective type I collagen (COL1A1/A2 genes). "Brittle bone disease".
- Clinical (📌 OI-FEATURES):
- Multiple fractures, minimal trauma.
- Blue sclerae (thin, visible choroid).
- Hearing loss (conductive/mixed).
- Dentinogenesis imperfecta (opalescent teeth).
- Short stature, scoliosis, wormian bones.
- Sillence Types:
- I: Mild, blue sclerae.
- II: Perinatal lethal (most severe).
- III: Progressive deforming.
- IV: Moderate, normal sclerae.
- Radiology: Osteopenia, thin cortices, bowing, "codfish" vertebrae, popcorn epiphyses.

- Management: Multidisciplinary.
- Medical: Bisphosphonates (pamidronate) ↓ fractures, ↑ bone density.
- Surgical: Intramedullary rodding (Fassier-Duval rods).
- Supportive: Physio, dental, hearing aids.
⭐ Type II OI is the most severe form, often leading to perinatal lethality due to severe skeletal fragility and respiratory complications.
High‑Yield Points - ⚡ Biggest Takeaways
- Primarily a Type I collagen synthesis defect (COL1A1/COL1A2 genes).
- Classic triad: blue sclerae, recurrent fractures with minimal trauma, and hearing loss.
- Dentinogenesis imperfecta (opalescent teeth) is a frequent finding.
- Sillence classification: Type I (mildest, most common), Type II (most severe, lethal in perinatal period).
- Wormian bones on skull X-ray and generalized osteopenia are characteristic.
- Management focuses on bisphosphonates, fracture prevention, and surgical correction of deformities.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more
